688315.SH
诺禾致源
SSE · Healthcare · Biotechnology · CN
CNY 16.93
+6.14%Margins
Gross margin
43.0%
EBITDA margin
14.4%
EBIT margin
8.5%
Net margin
7.2%
FCF margin
5.8%
6.1%
Return on equity
4.2%
Return on assets
7.1%
Return on invested capital
0.58x
Asset turnover
CNY 246.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026